Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» US FDA approves Onsolis to manage breakthrough pain in cancer patients
US FDA approves Onsolis to manage breakthrough pain in cancer patients
US FDA approves Onsolis to manage breakthrough pain in cancer patients
Submitted by
admin
on July 18, 2009 - 10:58am
Source:
Pharmabiz
News Tags:
BioDelivery Sciences
Meda AB
Onsolis
Headline:
US FDA approves Onsolis to manage breakthrough pain in cancer patients
Do Not Allow Advertisers to Use My Personal information
